Anna Sofie Koefoed

Dr. Anna Sofie Koefoed

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2021 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
SASilja M. Axelsen
Silja M. Axelsen
UKUlla Kampmann
Ulla Kampmann
AKAnna Sofie Koefoed
Anna Sofie Koefoed
DMDavid McIntyre
David McIntyre
POPer G. Ovesen
Per G. Ovesen
JFJens Fuglsang
Jens Fuglsang

21 May 2024 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
AKAnna Sofie Koefoed
Anna Sofie Koefoed
SKSine Knorr
Sine Knorr
JFJens Fuglsang
Jens Fuglsang
MLMagnus Leth-Møller
Magnus Leth-Møller
AHAdam Hulman
Adam Hulman
UKUlla Kampmann
Ulla Kampmann
OBJECTIVE: To identify and characterize groups of pregnant women with type 2 diabetes with distinct hemoglobin A1c (HbA1c) trajectories across gestation and to examine the association with adverse obstetric and perinatal outcomes. RESEARCH DESIGN AND METHODS: This was a retrospective Danish national cohort study including all singleton pregnancies in women with type 2 diabetes, giving birth to a liveborn infant, between 2004 and 2019. HbA1c trajectories were identified using latent class linear mixed-model analysis. Associations with adverse outcomes were examined with logistic regression models. RESULTS: A total of 1,129 pregnancies were included. Three HbA1c trajectory groups were identified and named according to the glycemic control in early pregnancy (good, 59%; moderate, 32%; and poor, 9%). According to the model, all groups attained an estimated HbA1c <6.5% (48 mmol/mol) during pregnancy, with no differences between groups in the 3rd trimester. Women with poor glycemic control in early pregnancy had lower odds of having an infant with large-for-gestational-age (LGA) birth weight (adjusted odds ratio [aOR] 0.57, 95% CI 0.40–0.83), and higher odds of having an infant with small-for-gestational age (SGA) birth weight (aOR 2.49, 95% CI 2.00–3.10) and congenital malformation (CM) (aOR 4.60 95% CI 3.39–6.26) compared with women with good glycemic control. There was no evidence of a difference in odds of preeclampsia, preterm birth, and caesarean section between groups. CONCLUSIONS: Women with poor glycemic control in early pregnancy have lower odds of having an infant with LGA birth weight, but higher odds of having an infant with SGA birth weight and CM.

23 June 2025 in Diabetic Medicine
Verified
Journal Article
Open access
NLNinna L. Larsen
Ninna L. Larsen
AKAnna Sofie Koefoed
Anna Sofie Koefoed
UKUlla Kampmann
Ulla Kampmann
RRRavi Retnakaran
Ravi Retnakaran
POPer Ovesen
Per Ovesen
JFJens Fuglsang
Jens Fuglsang
Aims: To compare markers of glycaemic regulation in twin and singleton pregnancies in women with gestational diabetes mellitus (GDM).Methods: A retrospective case–control study was performed. 53 twin and 212 matched singleton pregnant women with gestational diabetes were included. Data were obtained from patient files. Twin and singleton pregnant women were compared regarding clinical characteristics and parameters related to glucose metabolism.Results: Compared to singleton pregnant women, twin pregnant women were diagnosed with GDM earlier in pregnancy (gestational age (GA) (weeks + days) 24 + 5 ± 5 + 2 vs. GA 27 + 2 ± 5 + 2; p = 0.002). The proportion of women treated with insulin was similar (24.1% vs. 24.5%, p = 1.0), but in twin pregnancies, insulin treatment was commenced earlier (GA 25 + 2 ± 4 + 6 vs. GA 30 + 1 ± 5 + 0; p = 0.003). At diagnosis, the HbA1c value was significantly lower in twin pregnant women (34 (5.3) ± 4.8 (2.6) vs. 35.9 (5.4) ± 5.4 (2.6), p = 0.03), but mean HbA1c values were similar in 2nd (33.9 (5.3) ± 4.6 (2.6) vs. 35.7 (5.4) ± 5.3 (2.6), p = 0.16) and 3rd trimester (35.1 (5.5) ± 4.2 (2.5) vs. 36.0 (5.4) ± 5.1 (2.6), p = 0.25).Conclusions: We have characterized the effect of twin pregnancy on parameters of glucose metabolism and glycaemic control in GDM in one of the largest studies of twin pregnant women with GDM to date. We conclude that twin pregnant women may have the GDM diagnosis earlier, but diurnal insulin requirements and HbA1c levels are comparable with singleton pregnant women.

10 July 2023 in Reproductive Medicine
Verified
Journal Article
Open access
PDF file
AKAnna Sofie Koefoed
Anna Sofie Koefoed
HMH. David McIntyre
H. David McIntyre
KGKristen S. Gibbons
Kristen S. Gibbons
CPCharlotte W. Poulsen
Charlotte W. Poulsen
JFJens Fuglsang
Jens Fuglsang
POPer G. Ovesen
Per G. Ovesen
Gestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes including large for gestational age infants. Individualizing the management of women with GDM based on the likelihood of needing insulin may improve pregnancy outcomes. The aim of this study is to identify characteristics associated with a need for insulin in women with GDM, and to develop a predictive model for insulin requirement. A historical cohort study was conducted among all women with GDM in a singleton pregnancy at Aarhus University Hospital from 2012 to 2017. Variables associated with insulin treatment were identified through multivariable logistic regression. The variables were dichotomized and included in a point scoring system aiming to predict the likelihood of needing insulin. Seven variables were associated with needing insulin: family history of diabetes, current smoker, multiparity, prepregnancy body mass index, gestational age at the oral glucose tolerance test (OGTT), 2-h glucose value at the OGTT and hemoglobin A1c at diagnosis. A risk score was calculated assigning one point to each variable. On ROC analysis, a cut-off value of ≥3 points optimally predicted a requirement for insulin. This prediction model may be clinically useful to predict requirement for insulin treatment after further validation.

9 September 2025 in Journal of the Endocrine Society
Verified
Journal Article
Open access
AKAnna Sofie Koefoed
Anna Sofie Koefoed
POPer Ovesen
Per Ovesen
JFJens Fuglsang
Jens Fuglsang
AFAstrid Fur
Astrid Fur
DJDorte Moeller Jensen
Dorte Moeller Jensen
UKUlla Kampmann
Ulla Kampmann
Context: The prevalence of type 2 diabetes (T2DM) in pregnancy is increasing rapidly worldwide. Consequently, there is a need to gain more knowledge about pregnant women with T2DM. Objective: The current study aimed to assess the prevalence of cardiometabolic risk factors and comorbidities in women with T2DM before and during pregnancy, and to evaluate associations with adverse obstetric and perinatal outcomes. A comparison between women with preexisting T2DM (P-T2DM) and women with T2DM first recognized during pregnancy (N-T2DM) was also performed. Design: A retrospective Danish national population-based cohort study, including all pregnancies in women with T2DM, giving birth to a live infant after 24 weeks of gestation, from 2004 until 2019. Results: The population included 1297 pregnancies in women with T2DM (1207 P-T2DM, 90 N-T2DM). Before pregnancy, 20.4% smoked, 13.4% had chronic hypertension, 12.5% had dyslipidemia, and 63.1% had obesity. Only 58.6% of women with P-T2DM entered pregnancy with hemoglobin A1c (HbA1c) < 53 mmol/mol (7.0%). During pregnancy, 73.4% had an excessive weight gain, and 21.6% attained a median HbA1c < 38 mmol/mol (5.6%). Preeclampsia was observed in 9.1% of women, preterm delivery in 19.0%, and large-for-gestational-age birthweight in 32.2% of infants. Obstetric and perinatal outcomes were similar in women with P-T2DM and N-T2DM. All modifiable exposures were associated with one or more severe adverse outcomes. Conclusion: Cardiometabolic risk factors are prevalent in pregnant women with T2DM and are associated with severe adverse outcomes for mother and child.